Effect of Previous Anticoagulant Treatment on Risk of COVID-19.

Maruxa Zapata-Cachafeiro Ángela Prieto-Campo Manuel Portela Romero Eduardo Carracedo-Martínez Martina Lema-Oreiro María Piñeiro-Lamas Somnath Chaudhuri Ángel Salgado-Barreira Adolfo Figueiras

Published in: Drug safety (2022)

The results of this study have shown that antivitamin K anticoagulants and direct-acting anticoagulants do not increase the risk of progression to more severe stages. Antivitamin K consumption was associated with a lower risk of hospitalization and susceptibility to infection.

Keyphrases

coronavirus disease
sars cov
atrial fibrillation
venous thromboembolism
early onset
drug induced
respiratory syndrome coronavirus